SNPHF   $9.0  -1.96% Market Closed

SANTEN PHARM CO
Total Cash 89.74B
totalCashPerShare 252.336
EBITDA 71.44B
Total Debt 0.00
quickRatio 1.928
currentRatio 2.601
Total Revenue 304.35B
debtToEquity
Revenue/Share 837.311
ROA 0.07728
ROE 0.08875
grossProfits
freeCashflow 70.45B
operatingCashflow 82.24B
earningsGrowth 0.06
revenueGrowth 0.033
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.17594999
profitMargins 0.0
enterpriseValue -86.27B
forwardPE 14.154763
floatShares
sharesOutstanding 348.72M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.03%
heldPercentInstitutions 0.53%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 862.32
Price To Book help_outline 0.01
earningsQuarterlyGrowth 0.02
netIncomeToCommon 26.85B
trailingEps 0.49%
forwardEps 0.84%
enterpriseToEbitda -1.21
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.18 3Q 2024
institutionsCount 205
lastUpdated Nov. 7, 2024, 1:44 a.m.